share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Real-time News ·  May 6, 2022 21:09

 

Gainers

  • iRhythm Technologies (NASDAQ:IRTC) stock rose 21.6% to $143.58 during Friday's pre-market session. The company's market cap stands at $4.2 billion. As per the news, the Q1 earnings report came out yesterday.
  • Cue Biopharma (NASDAQ:CUE) shares moved upwards by 14.99% to $4.6. The market value of their outstanding shares is at $162.7 million.
  • Sensus Healthcare (NASDAQ:SRTS) shares moved upwards by 11.73% to $8.0. The company's market cap stands at $133.4 million. As per the press release, Q1 earnings came out yesterday.
  • LogicBio Therapeutics (NASDAQ:LOGC) stock rose 10.85% to $0.61. The market value of their outstanding shares is at $20.1 million.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 8.77% to $0.23. The company's market cap stands at $33.5 million.
  • ChemoCentryx (NASDAQ:CCXI) shares increased by 8.69% to $17.0. The market value of their outstanding shares is at $1.2 billion. The company's, Q1 earnings came out yesterday.

Losers

  • Endo International (NASDAQ:ENDP) shares fell 38.1% to $1.25 during Friday's pre-market session. The company's market cap stands at $293.8 million. As per the press release, Q1 earnings came out yesterday.
  • T2 Biosystems (NASDAQ:TTOO) stock fell 18.71% to $0.31. The market value of their outstanding shares is at $53.5 million. As per the news, the Q1 earnings report came out yesterday.
  • Kintara Therapeutics (NASDAQ:KTRA) shares decreased by 10.48% to $0.19. The market value of their outstanding shares is at $12.4 million.
  • Sonoma Pharmaceuticals (NASDAQ:SNOA) shares decreased by 10.32% to $3.13. The market value of their outstanding shares is at $9.6 million.
  • Monopar Therapeutics (NASDAQ:MNPR) stock declined by 9.1% to $2.0. The market value of their outstanding shares is at $25.2 million.
  • Vanda Pharmaceuticals (NASDAQ:VNDA) stock fell 8.17% to $9.0. The market value of their outstanding shares is at $508.4 million. The company's, Q1 earnings came out yesterday. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment